Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Japan Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20061
20074
20092
20101
20113
20122
20133
20144
20151
20164
20172
20182
20202
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wakayama Medical University6
Boehringer Ingelheim2
Boston Scientific Corporation2
Novartis Pharmaceuticals2
Osaka Medical Center for Cancer and Cardiovascular Diseases2
Pfizer2
Sumitomo Pharma America, Inc.2
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Azienda Ospedaliera Universitaria Integrata Verona1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms39
Neoplasms6
Bile Duct Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Adenocarcinoma2
Biliary Tract Neoplasms2
Breast Neoplasms2
Digestive System Diseases2
Digestive System Neoplasms2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.